Time is Brain

𝗕𝗿𝗮𝗶𝗡𝟮𝟬® 𝗵𝗮𝘀 𝗼𝗯𝘁𝗮𝗶𝗻𝗲𝗱 𝗖𝗘 𝗺𝗮𝗿𝗸𝗶𝗻𝗴 𝘂𝗻𝗱𝗲𝗿 𝘁𝗵𝗲 𝗘𝗨 𝗠𝗗𝗥 🇪🇺 A major step towards bringing Real-Time Brain Intelligence into clinical practice across Europe. By transforming brain signals into continuous, actionable clinical insights, BraiN20® is designed to support better-informed decisions throughout the stroke and other neurological disorders care. We are now closer than ever to bringing our technology to hospitals, healthcare professionals and stroke patients. Better-informed decisions through continuous insight. The era of Real-Time Brain Intelligence is here. #TimeIsBrain #BraiN20 #CEMarking #RealTimeStrokeIntelligence #StrokeCare #MedTech #eicAccelerator

🧠 Time is Brain  | Innovación para cambiar el futuro del ictus  #Ship2BAlumni La medtech Time is Brain, alumni de nuestra fundación, afronta una nueva etapa de crecimiento con una ronda de financiación de 𝟮,𝟱 𝗺𝗶𝗹𝗹𝗼𝗻𝗲𝘀 𝗱𝗲 𝗲𝘂𝗿𝗼𝘀 para impulsar el lanzamiento al mercado de su tecnología de monitorización cerebral en tiempo real para pacientes con ictus. La compañía ha desarrollado una solución pionera que permite monitorizar la viabilidad cerebral durante la trombectomía mecánica, ayudando a los equipos médicos a tomar decisiones más rápidas y precisas cuando cada minuto cuenta. Tras captar cerca de 800.000€ en una de las campañas más exitosas de Capital Cell , la compañía se encuentra en la fase final para obtener el marcado CE y acercar esta innovación a hospitales y pacientes. 📈 Además, la ronda actualmente abierta ya ha alcanzado el 88,6% de su objetivo de financiación, reflejando el interés que está despertando esta tecnología entre los inversores. 👏 Enhorabuena a Alicia Martínez Piñeiro, Antoni Dávalos, Jaume Coll-Cantí, y a todo el equipo de Time is Brain por seguir impulsando soluciones que combinan ciencia, tecnología e impacto para mejorar el pronóstico de una de las principales causas de discapacidad en el mundo. 🔗 Más información sobre la oportunidad de inversión: https://lnkd.in/eiKXwBf4

We are grateful to Conecta for featuring Time is Brain in the Radar Startup section of its second edition, dedicated to silent innovation: the kind of innovation that does not seek noise, but focuses on making things work better. At Time is Brain, this idea resonates deeply with our mission. With #BraiN20®, we are working to bring real-time stroke intelligence closer to clinical decision-making, where every second matters. Thank you to the Conecta team for giving visibility to companies that are building technology with purpose, clinical ambition and real-world impact. Initiatives like this help connect innovation, industry, healthcare and society and highlight the people and teams working behind the scenes to move critical fields forward. Proud to be included alongside other startups contributing to the future of innovation. Time is Brain: Real-time stroke intelligence. #TimeIsBrain #BraiN20 #StrokeCare #Neurotechnology #HealthTech #MedTech #Innovation #Startup #ImpactInnovation #ConectaIndustria #eicAccelerator

⭐ 𝗡𝗲𝘄 𝗜𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 𝗢𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝘆: Time is Brain Time is Brain, a spin-off from Germans Trias Hospital in Barcelona, has developed BraiN20®, a technology designed to 𝗺𝗼𝗻𝗶𝘁𝗼𝗿 𝗯𝗿𝗮𝗶𝗻 𝘃𝗶𝗮𝗯𝗶𝗹𝗶𝘁𝘆 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗼𝘂𝘀𝗹𝘆 𝘁𝗵𝗿𝗼𝘂𝗴𝗵𝗼𝘂𝘁 𝘁𝗵𝗲 𝘀𝘁𝗿𝗼𝗸𝗲 𝗰𝗮𝗿𝗲 𝗽𝗮𝘁𝗵𝘄𝗮𝘆, 𝗳𝗿𝗼𝗺 𝘁𝗵𝗲 𝗮𝗺𝗯𝘂𝗹𝗮𝗻𝗰𝗲 𝘁𝗼 𝘁𝗵𝗲 𝗵𝗼𝘀𝗽𝗶𝘁𝗮𝗹. Every 3 seconds, someone in the world suffers a stroke. Over the last decades, healthcare systems have significantly improved stroke treatment. Yet one critical challenge remains: clinicians still lack a way to continuously monitor what is happening inside the brain in real time. Today, most treatment decisions rely on snapshots from CT or MRI scans. Valuable information can be lost between those moments. The potential impact is significant: • Real-time monitoring of stroke evolution • Faster and more informed treatment decisions • Earlier identification of patients eligible for intervention • Clinical data suggesting predictive performance beyond standard imaging approaches < To learn more about Time is Brain: https://lnkd.in/eVBr_ifn > For those who have been following Capital Cell for a while, Time is Brain may sound familiar. In 2021, the company raised nearly €800,000 in less than 24 hours while still validating its prototype. Today, the company returns at a very different stage. A few reasons why this opportunity stands out: • CE Marking expected before July and FDA submission underway • Clinical validation through the PROMISE trial involving more than 200 patients • Founded by leading stroke neurologists, including Dr. Antonio Dávalos, a key contributor to international stroke treatment guidelines • Strong backing from The Foundry, which is investing €1.5M in the round Time is Brain is currently raising €2.5M to support its commercial launch in Europe and the United States. With regulatory approval approaching and market entry ahead, the company is entering one of the most important phases of its growth journey. < To invest in Time is Brain: https://lnkd.in/eVBr_ifn >

⭐ 𝗡𝗲𝘄 𝗜𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 𝗢𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝘆: Time is Brain Time is Brain, a spin-off from Germans Trias Hospital in Barcelona, has developed BraiN20®, a technology designed to 𝗺𝗼𝗻𝗶𝘁𝗼𝗿 𝗯𝗿𝗮𝗶𝗻 𝘃𝗶𝗮𝗯𝗶𝗹𝗶𝘁𝘆 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗼𝘂𝘀𝗹𝘆 𝘁𝗵𝗿𝗼𝘂𝗴𝗵𝗼𝘂𝘁 𝘁𝗵𝗲 𝘀𝘁𝗿𝗼𝗸𝗲 𝗰𝗮𝗿𝗲 𝗽𝗮𝘁𝗵𝘄𝗮𝘆, 𝗳𝗿𝗼𝗺 𝘁𝗵𝗲 𝗮𝗺𝗯𝘂𝗹𝗮𝗻𝗰𝗲 𝘁𝗼 𝘁𝗵𝗲 𝗵𝗼𝘀𝗽𝗶𝘁𝗮𝗹. Every 3 seconds, someone in the world suffers a stroke. Over the last decades, healthcare systems have significantly improved stroke treatment. Yet one critical challenge remains: clinicians still lack a way to continuously monitor what is happening inside the brain in real time. Today, most treatment decisions rely on snapshots from CT or MRI scans. Valuable information can be lost between those moments. The potential impact is significant: • Real-time monitoring of stroke evolution • Faster and more informed treatment decisions • Earlier identification of patients eligible for intervention • Clinical data suggesting predictive performance beyond standard imaging approaches < To learn more about Time is Brain: https://lnkd.in/eVBr_ifn > For those who have been following Capital Cell for a while, Time is Brain may sound familiar. In 2021, the company raised nearly €800,000 in less than 24 hours while still validating its prototype. Today, the company returns at a very different stage. A few reasons why this opportunity stands out: • CE Marking expected before July and FDA submission underway • Clinical validation through the PROMISE trial involving more than 200 patients • Founded by leading stroke neurologists, including Dr. Antonio Dávalos, a key contributor to international stroke treatment guidelines • Strong backing from The Foundry, which is investing €1.5M in the round Time is Brain is currently raising €2.5M to support its commercial launch in Europe and the United States. With regulatory approval approaching and market entry ahead, the company is entering one of the most important phases of its growth journey. < To invest in Time is Brain: https://lnkd.in/eVBr_ifn >

This week, our CEO Alicia Martínez had the opportunity to be in Brussels 🇪🇺 for the EIC Summit. At Time is Brain, we are proud to be part of the European Innovation Council and SMEs Executive Agency (EISMEA) family. Since receiving the EIC Accelerator, we have shared several years of collaboration, growth and commitment to advancing #BraiN20®, our real-time brain monitoring technology, closer to clinical practice. Being part of this event is special for many reasons. It is a valuable opportunity to connect with key stakeholders across the healthcare ecosystem, including corporates, hospitals, public institutions and innovation leaders but also to reconnect in person with the EIC teams who have supported us throughout the project. A special thank you to our Project Officer, Inese V., for taking the time to meet with us, catch up and continue supporting the evolution of our project. Thank you, EIC, for backing visionary entrepreneurs and helping European innovation move forward. ❤️ #EICSummit #EICAccelerator #EuropeanInnovationCouncil #HealthTech #BraiN20 #Neurotechnology #StrokeCare #Innovation #TimeIsBrain

Last week, Time is Brain had the pleasure of participating in #ESOC2026, one of the leading international congresses in stroke and cerebrovascular care. It was a highly productive few days in Maastricht, showcasing #BraiN20® and engaging with clinicians, researchers and healthcare leaders who share a common goal: improving stroke care when every second counts. A big thank you to Gemma Molina and Antoni Dávalos for their fantastic participation and commitment, and congratulations to the European Stroke Organisation organisers for delivering an outstanding congress. Here are a few snapshots from the event and yes, Maastricht and the Netherlands absolutely rock! 🇳🇱 #TimeIsBrain #BraiN20 #ESOC2026 #StrokeCare #MedTech #HealthTech #Voiceofstroke #eicAccelerator

𝗧𝗶𝗺𝗲 𝗶𝘀 𝗕𝗿𝗮𝗶𝗻 𝗵𝗮𝘀 𝗯𝗲𝗲𝗻 𝘀𝗲𝗹𝗲𝗰𝘁𝗲𝗱 𝗮𝘀 𝗮 𝗠𝗼𝗯𝗶𝗹𝗲 𝗪𝗼𝗿𝗹𝗱 𝗖𝗮𝗽𝗶𝘁𝗮𝗹 𝗔𝘄𝗮𝗿𝗱𝘀 𝗳𝗶𝗻𝗮𝗹𝗶𝘀𝘁 We are proud to share that Time is Brain has been selected for the Mobile World Capital Awards final, among 17 finalists chosen from 298 applications across 62 countries. Our technology, #BraiN20®, is designed to support clinicians with accurate, real-time brain signal monitoring, helping bring neurological assessment closer to the patient. Being part of this global group of innovators is a meaningful milestone for our team, our partners, and everyone working to improve outcomes in time-critical neurological care. A big thank you to Mobile World Capital Barcelona and the strategic partners Red.es, Ministerio para la Transformación Digital y de la Función Pública, GSMA Foundry and B Lab Spain behind the awards for recognising technologies with the potential to create real-world impact. See you in Barcelona on June 18 at Casa Milà 👏 #TimeIsBrain #BraiN20 #MWCapitalAwards #MobileWorldCapital #StrokeCare #Neurotechnology #HealthTech #MedTech #Innovation #Barcelona #eicAccelerator

At Time is Brain, we are excited to be part of #ESOC2026 next week in Maastricht 🇳🇱 From May 6–8, our founders Alicia Martínez and Antoni Dávalos, together with our Clinical Specialist Gemma Molina, will be there showcasting our #BraiN20®, connecting with the stroke community and discussing the future of stroke care. We believe one of the biggest challenges in stroke is having the right information to make the right decision at the right moment, in real time. That’s why we are working to bring real-time brain monitoring into every critical moment of the patient journey. If you’re attending European Stroke Organisation congress, we’d love to meet you and exchange perspectives on how we can improve outcomes together. #StrokeCare #Neurotechnology #AIinHealthcare #MedTech #ESOC2026